O09 - Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitisation?
Main Authors: | Wickens, Kristin, Stanley, Thorsten, Mitchell, Edwin, Barthow, Christine, Fitzharris, Penny, Purdie, Gordon, Siebers, Robert, Black, Peter, Crane, Julian |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094203/ |
Similar Items
-
Influence of commercial inactivated yeast derivatives on the survival of probiotic bacterium Lactobacillus rhamnosus HN001 in an acidic environment
by: Mingzhan Toh, et al.
Published: (2017-07-01) -
The Probiotics in Pregnancy Study (PiP Study): rationale and design of a double-blind randomised controlled trial to improve maternal health during pregnancy and prevent infant eczema and allergy
by: Barthow, Christine, et al.
Published: (2016) -
Early allergen exposure and atopic eczema
by: Harris, J.M., et al.
Published: (2007) -
Vitamin D and the Development of Atopic Eczema
by: Palmer, Debra J.
Published: (2015) -
Microbiota in Healthy Skin and in Atopic Eczema
by: Baviera, Giuseppe, et al.
Published: (2014)